bioRxivBiochemistryPreprint
The proteomic toolbox for identification, quantification, and characterization of polyclonal antibodies
Abstract
Recent advances in proteomics and mass spectrometry facilitated the in-depth characterization of monoclonal antibodies and enabled innovative approaches for the quantification of polyclonal antibodies generated against numerous antigens. Human respiratory syncytial virus (RSV) is a contagious respiratory pathogen often manifested as a common cold infection in adults and more serious symptoms in infants and the elderly population. Here, we used a reference IgG1{kappa} monoclonal antibody NISTmAb 8671 and its affinity interaction with an RSV fusion glycoprotein F as a model to develop the proteomic toolbox for identification, quantification, and characterization of polyclonal antibodies. Our toolbox integrated a variety of proteomic and mass spectrometry approaches for accurate mass measurements of antibody fragments, antibody digestion with the complimentary proteases (trypsin, asparaginase, and proalanase), immunoaffinity enrichments, and bottom-up or middle-down proteomics. We measured absolute concentrations of anti-RSV antibody isotypes and subclasses in 69 serum samples of healthy individuals and revealed IgG1 (2,580 ng/mL), IgA1 (280 ng/mL), and IgM (180 ng/mL) as the most abundant isotypes. Interestingly, we also identified the presence of IgG2 (74 ng/ml), IgG4 (4.9 ng/mL) and IgA2 (5.5 ng/mL) antibodies. Interactome measurements detected the consistent co-precipitation of C1q complement complexes. Repertoire profiling of the variable regions of polyclonal antibodies revealed the frequent use of IGHV3 subgroup genes, while IGHV5-51 was the most abundant single gene of the anti-RSV polyclonal antibody response. The presented toolbox will facilitate the in-depth characterization of polyclonal antibodies and pave the way to quantitative approaches in serological studies and precision immunology.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteome-Wide Serology Identifies Secreted IgD against RSV Fusion Glycoprotein as a Signature of Broadly Elevated Antibody Response
Zoe Turner, Weize Tang, … Andrei P. Drabovich·bioRxiv·Nov 4, 2026
- RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera
Cassandra A. L. Simonich, Teagan E. McMahon, … Jesse D. Bloom·Journal of VirologyPeer-reviewed·Jul 3, 2025
- Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates
Paula Eillanny Silva Marinho, Dibya Ghimire, … Jacob E. Lemieux·Journal of VirologyPeer-reviewed·Oct 5, 2026
- Development and validation of a respiratory syncytial virus multiplex immunoassay
P. Marsall, M. Fandrich, … A. Dulovic·InfectionPeer-reviewed·Feb 8, 2024
- Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation
E. A. van Erp, A. J. Lakerveld, … P. B. van Kasteren·bioRxiv·Nov 4, 2019
- Potently neutralizing human monoclonal antibodies against the zoonotic pararubulavirus Sosuga virus
H. M. Parrington, N. Kose, … J. E. Crowe·bioRxiv·Nov 17, 2022